FILTER
Prikaži samo sadržaje koji zadovoljavaju:
objavljeni u periodu:
na jeziku:
hrvatski engleski
sadrže pojam:

HANFA receives request from Actavis, approves Barr's request to publish bid for Pliva takeover - extended

Autor: ;rmli;
ZAGREB, Aug 10 (Hina) - The Croatian agency for the supervision of financial services HANFA on Thursday stated that the Icelandic company Actavis had submitted a request for the approval of its bid to take over the Croatian pharmaceutical company Pliva and that HANFA had granted its approval for the US company Barr to publish its bid to take over Pliva.
ZAGREB, Aug 10 (Hina) - The Croatian agency for the supervision of financial services HANFA on Thursday stated that the Icelandic company Actavis had submitted a request for the approval of its bid to take over the Croatian pharmaceutical company Pliva and that HANFA had granted its approval for the US company Barr to publish its bid to take over Pliva.

HANFA said on its web site that Actavis Group submitted its request for HANFA to approve its takeover bid through its legal representative, a Zagreb law firm, on August 9. The deadline for the submission of the request was midnight August 9.

HANFA also said that at its session today it decided to grant its approval for the US corporation Barr Laboratories Europe B.V. The Netherlands to publish its takeover bid.

Barr had sent its request to HANFA on July 28.

The price offered by the US company is 743 kuna per share, which in total is slightly more than 13.8 billion kuna. The company has also secured bank guarantees from the London office of Bank of America. The US corporation has seven days to publish its takeover bid.

HANFA will decide about Actavis's request within the next 14 days.

Barr's concluding the offer will depend solely on the acquisition of more than 50 percent of Pliva's stock.

Pliva's shares have been traded lately on the Zagreb Stock Exchange at prices ranging from 806 to 810 kuna.

(1 EUR = 7.28 kuna)

(Hina) rml

An unhandled error has occurred. Reload 🗙